本次传出出售博士伦的消息，或许与博士康的当下困境密不可分。据报道，博士康现有债务为210亿美元，其中100亿美元将在2027年底前到期。然而由于博士伦是重要的创收子公司，母公司必须通过偿付能力测试，然后才能批准出售。

Bausch Health is rumored to be looking to sell its Bausch + Lomb business, which will ease bankruptcy concerns and upgrade ...

GSK will also gain the rights to Valeant's back-up compounds that target potassium channels. Valeant receives an upfront payment of $125 million, and will share up to 50% of net profits on ...

Shares of Bausch + Lomb (NYSE: BLCO) rallied 15.7% as of 3:07 p.m. ET today. The stock is surging today on news the company ...

Valeant helped found Philidor in 2013, and most of the drugs it dispensed were from Valeant. Prosecutors alleged Tanner passed inside information to Davenport to bolster Philidor's business.

Hedge fund managers sit on the boards of Bausch Health and Bausch + Lomb. They don’t think like your typical corporate board, ...

Bausch + Lomb was put up for sale after a planned separation from its parent company Bausch Health, formerly known as Valeant ...

So if you see this the way Allergan does Valeant has every reason to want this deal done as soon as possible. Valeant doesn't want Bausch & Lomb to disappoint. Besides making Allergan shareholders ...

Canada-based Valeant Pharmaceuticals announced on August 20 that it had entered into a definitive agreement to buy Sprout Pharmaceuticals for $1bn, with the opportunity for Sprout to enjoy a share of ...

根据最近的监管文件显示，Bausch Health Companies Inc. (NYSE:BHC)的执行副总裁兼总法律顾问Seana Carson出售了部分公司股票。2024年9月6日，Carson以平均6.21美元的价格出售了13,370股普通股，总计约83,027美元。 此次出售是根据Carson于2023年11月6日采用的Rule 10b5-1交易计划进行的。这类计划允许公司内部人员在预 ...

This 2017 business report presents Valeant's course of business throughout the respective business year. The report complies with the disclosure requirement for corporate entities and generally ...

Andrew Left is fighting a range of criminal and civil charges related to his trading practices, and other investors who make ...